Epic Research is not viewable using Internet Explorer. Please try accessing it with an alternate browser.
Cosmos Study

Hospitalizations for Flu and Its Complications Higher in the 2024/2025 Season Than Other Recent Flu Seasons

July 24, 2025
Dual-Team Study
Team A:Louis Kazaglis, MDGregory Edwards, PhD
Team B:Sam Butler, MDEric Barkley

Key Findings

  • Hospitalization rates in the 30 days following an influenza infection have risen in recent seasons, from 4.9% in 2022/2023, 5.6% in 2023/2024, and 7.0% in 2024/2025. Before the COVID-19 pandemic, rates trended slightly down, reaching 4.2% in the 2019/2020 season. 
  • 35.9% of patients with confirmed influenza in the 2023/2024 season and 35.0% of patients with confirmed influenza in the 2024/2025 season visited the emergency department (ED) within 30 days of their influenza infection—the highest rates in the past 12 seasons. 

Seasonal influenza remains a significant contributor to healthcare burden in the United States, causing annual spikes in emergency department visits and hospitalizations. While year-to-year variability is common, broader shifts have occurred in recent seasons. In particular, the aftermath of the COVID-19 pandemic brought about changes in public health behaviors, population immunity, and viral circulation patterns. Amid these changes, early reports from the 2024/2025 flu season suggested more severe presentations and higher demand for acute care services.1 This study was designed to quantify recent trends in flu-related emergency department visits, hospitalizations, and complications, building on more than a decade of data to contextualize the current season within historical patterns. 

We examined data from 11 million patients with medically attended influenza infections recorded between August 1, 2013, and April 19, 2025. An influenza infection was identified by a positive lab test or a clinical diagnosis of flu. We then looked for a flu-related hospitalization or emergency department (ED) visit within the following 30 days, which were defined as those with an influenza diagnosis or a secondary condition commonly associated with an influenza infection, including COPD, heart failure, and acute necrotizing hemorrhagic encephalopathy. 

Over the past 12 flu seasons, the rate of flu-related ED visits has been the highest in the three most recent seasons. In 2022/2023, 33.1% of patients with influenza visited the ED within 30 days of the infection. This increased slightly to 35.9% in 2023/2024 and remained elevated at 35.0% in 2024/2025. For comparison, just 24.1% of patients visited the ED within 30 days of infection in the 2012/2013 season, highlighting the substantial rise in acute care use in recent years. 

Similarly, the proportion of patients hospitalized within 30 days of a flu infection has risen in recent seasons. In the 2022/2023 season, 4.9% of patients were hospitalized within 30 days of a flu infection. This increased to 5.6% in 2023/2024 and further to 7.0% in 2024/2025.  

Figure 1
Flu-Related Hospitalization and ED Visit Rates
Flu-Related Hospitalization and ED Visit Rates
Figure 1. The annual rate of flu-related hospitalizations and ED visits within 30 days of a positive flu test or flu diagnosis.

These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 299 million patient records from 1,700 hospitals and more than 40,000 clinics from all 50 U.S. states, Lebanon, and Saudi Arabia. This study was completed by two teams that worked independently, each composed of a clinician and research scientists. The two teams came to similar conclusions. Graphics by Brian Olson. 

  1. Preliminary estimated flu disease burden 2024-2025 flu season. U.S. Centers for Disease Control and Prevention. March 28, 2025. https://www.cdc.gov/flu-burden/php/data-vis/2024-2025.html. Accessed April 3, 2025. 

Data Definitions

Study period
Study population
Influenza Season
Outcomes
Confounders
Influenza infection
Influenza-related hospitalizations or ED visits
Influenza-related complications
Race and ethnicity
Influenza vaccination
COPD
Heart failure
Acute necrotizing hemorrhagic encephalopathy
Model specifications
Limitations